Quality of Life(QoL) in Korean Postmenopausal Osteoporosis Patients With Bisphosphonate Treatment

NCT01227369 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4376

Last updated 2017-06-07

No results posted yet for this study

Summary

Quality of Life (QoL) in Korean postmenopausal osteoporosis patients with bisphosphonate treatment

Conditions

  • Osteoporosis, Postmenopausal

Interventions

OTHER

OPSAT-Q

A linguistically validated Korean version of OPSAT-Q

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2009-11-30
Completion
2009-11-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01227369 on ClinicalTrials.gov